ScoreWhy is Beijing Bohui Innovation Biotechnology Group Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.11%
- The company has been able to generate a Return on Capital Employed (avg) of 1.11% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 4.77% and Operating profit at -198.92% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 0.69% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.77% and Operating profit at -198.92% over the last 5 years
4
The company has declared negative results for the last 3 consecutive quarters
- The company has declared negative results in Sep 24 after 6 consecutive negative quarters
- NET SALES(HY) At CNY 399.89 MM has Grown at -18.88%
- INTEREST(9M) At CNY 23.69 MM has Grown at 15.51%
- NET PROFIT(Q) At CNY -4.04 MM has Fallen at -274.95%
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -5.41%, its profits have fallen by -216.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beijing Bohui Innovation Biotechnology Group Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Beijing Bohui Innovation Biotechnology Group Co., Ltd.
4.31%
0.49
35.15%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.77%
EBIT Growth (5y)
-198.92%
EBIT to Interest (avg)
-0.09
Debt to EBITDA (avg)
8.80
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.39
Tax Ratio
24.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.11%
ROE (avg)
0.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.03
EV to EBIT
-243.71
EV to EBITDA
54.92
EV to Capital Employed
2.21
EV to Sales
6.71
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.91%
ROE (Latest)
-5.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
CASH AND EQV(HY)
Highest at CNY 364.11 MM
-27What is not working for the Company
NET SALES(HY)
At CNY 399.89 MM has Grown at -18.88%
INTEREST(9M)
At CNY 23.69 MM has Grown at 15.51%
NET PROFIT(Q)
At CNY -4.04 MM has Fallen at -274.95%
OPERATING CASH FLOW(Y)
Lowest at CNY -99 MM
PRE-TAX PROFIT(Q)
At CNY 2.44 MM has Fallen at -50.89%
RAW MATERIAL COST(Y)
Grown by 12.88% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 79.27 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.5%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.9%
OPERATING PROFIT MARGIN(Q)
Lowest at 4.88 %
Here's what is working for Beijing Bohui Innovation Biotechnology Group Co., Ltd.
Cash and Eqv
Highest at CNY 364.11 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Beijing Bohui Innovation Biotechnology Group Co., Ltd.
Net Sales
At CNY 399.89 MM has Grown at -18.88%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Net Profit
At CNY -4.04 MM has Fallen at -274.95%
over average net sales of the previous four periods of CNY 2.31 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 23.69 MM has Grown at 15.51%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Pre-Tax Profit
At CNY 2.44 MM has Fallen at -50.89%
over average net sales of the previous four periods of CNY 4.98 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Operating Cash Flow
Lowest at CNY -99 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit Margin
Lowest at 4.88 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at 79.27 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 0.5%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 5.9%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 12.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
